PI3K regulatory subunits lose control in cancer.

Abstract excerpt

The PI3K signaling axis is frequently activated in cancer resulting from inactivation of its negative regulator PTEN or activating mutations of the p110alpha catalytic subunit of PI3K. In this issue of Cancer Cell, Jaiswal et al. report that mutations in the p85alpha regulatory subunit of PI3K can also activate this pathway in cancer.

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Catalytic Domain
• Share to PTEN gene
• Share to Mutation